SAFETY AND EFFECTIVENESS OF PEMETREXED IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN JAPAN BASED ON POST-MARKETING SURVEILLANCE

被引：0
作者：
Okubo, Sumiko [1 ]
Kobayashi, Noriko [1 ]
Taketsuna, Masanori [1 ]
Enatsu, Sotaro [1 ]
Nishiuma, Shinichi [1 ]
机构：
[1] Eli Lilly Japan, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 11期
关键词：
Post-Marketing Surveillance; NSCLC; Pemetrexed;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-011
引用
收藏
页码：S485 / S485
页数：1
相关论文
共 50 条
  • [41] Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
    Tetsuhiro Tanaka
    Masaomi Nangaku
    Enyu Imai
    Yoshiharu Tsubakihara
    Masatoshi Kamai
    Michihito Wada
    Shinji Asada
    Tadao Akizawa
    Clinical and Experimental Nephrology, 2019, 23 : 231 - 243
  • [42] Clinical Efficacy of Bevacizumab Concomitant with Pemetrexed in Patients with Advanced Non-small Cell Lung Cancer
    Zhang, Yu-Mei
    Li, Yong-Qiang
    Liu, Zhi-Hui
    Liao, Xiao-Li
    Liang, Rong
    Lin, Yan
    Yuan, Chun-Ling
    Liao, Si-Na
    Liang, Chao-Yong
    Li, Qian
    Li, Le-Qun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (08) : 3447 - 3450
  • [43] Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis
    Takeuchi, Tsutomu
    Kawai, Shinichi
    Yamamoto, Kazuhiko
    Harigai, Masayoshi
    Ishida, Kota
    Miyasaka, Nobuyuki
    MODERN RHEUMATOLOGY, 2014, 24 (01) : 8 - 16
  • [44] Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
    Kanamori, Rie
    Yamane, Shiho
    Seto, Takeshi
    ADVANCES IN THERAPY, 2021, 38 (09) : 4949 - 4960
  • [45] Safety and Effectiveness of Elotuzumab in Japanese Patients with Relapsed/Refractory Multiple Myeloma: A Post-marketing Surveillance Study
    Kaneko, Fumiya
    Suzuka, Hiroshi
    Yoshino, Tomoaki
    Hinosugi, Ryosuke
    INTERNAL MEDICINE, 2024, 63 (22) : 3039 - 3048
  • [46] Safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 524 patients: results from an interim analysis of post-marketing surveillance in Japan
    Tachibana, Yosuke
    Sato, Ryusuke
    Makioka, Haruki
    Hoshino, Misuzu
    Jin, Mingshou
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (11) : 1185 - 1197
  • [47] Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
    Tanaka, Tetsuhiro
    Nangaku, Masaomi
    Imai, Enyu
    Tsubakihara, Yoshiharu
    Kamai, Masatoshi
    Wada, Michihito
    Asada, Shinji
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2019, 23 (02) : 231 - 243
  • [48] Pemetrexed in first-line treatment of non-small cell lung cancer
    Esteban, Emilio
    Casillas, Marta
    Cassinello, Alejo
    CANCER TREATMENT REVIEWS, 2009, 35 (04) : 364 - 373
  • [49] Safety and effectiveness of alectinib in a real-world surveillance study in patients with ALK-positive non-small-cell lung cancer in Japan
    Masuda, Noriyuki
    Ohe, Yuichiro
    Gemma, Akihiko
    Kusumoto, Masahiko
    Yamada, Ikuyo
    Ishii, Tadashi
    Yamamoto, Nobuyuki
    CANCER SCIENCE, 2019, 110 (04) : 1401 - 1407
  • [50] Final Analysis of Post-Marketing Surveillance for Avelumab plus Axitinib in Patients With Renal Cell Carcinoma in Japan
    Nonomura, Norio
    Ito, Taito
    Sato, Masashi
    Morita, Makiko
    Ogi, Mie
    Kajita, Masahiro
    Oya, Mototsugu
    CANCER MEDICINE, 2025, 14 (02):
12345